| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $13.3M | -25.7% |
| SG&A Expense | $5.0M | -12.2% |
| Operating Income | -$18.4M | +22.4% |
| Pre-tax Income | -$17.5M | -31.5% |
| Income Tax | $800 | +0.0% |
| Net Income | -$17.5M | -31.5% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.1M | -9.5% |
| Accounts Receivable | $1.3M | -62.0% |
| Current Assets | $9.1M | -24.8% |
| Total Assets | $11.6M | -20.6% |
| Current Liabilities | $2.1M | +46.8% |
| Total Liabilities | $2.2M | +43.1% |
| Stockholders' Equity | $9.4M | -28.1% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.3M | +10.1% |
| Capital Expenditures | $6K | -8.0% |
| Investing Cash Flow | -$6K | +8.0% |
| Financing Cash Flow | $11.6M | -18.0% |
| Free Cash Flow | -$12.3M | +10.1% |